Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Patel SB

No contact information in database for Patel SB




    Title: Phytochemical Studies on Two Unexplored Endemic Medicinal Plants of India, Barleria terminalis and Calacanthus grandiflorus
    Otari SS, Patel SB, Lekhak MM, Ghane SG
    Ref: Front Pharmacol, 12:817885, 2021 : PubMed

            

    Title: Phyto-constituents profiling of Luffa echinata and in vitro assessment of antioxidant, anti-diabetic, anticancer and anti-acetylcholine esterase activities
    Patel SB, Ghane SG
    Ref: Saudi J Biol Sci, 28:3835, 2021 : PubMed

            

    Title: Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
    Patel DV, Patel NR, Kanhed AM, Patel SP, Sinha A, Kansara DD, Mecwan AR, Patel SB, Upadhyay PN and Yadav MR <5 more author(s)>
    Ref: ACS Chem Neurosci, 10:3635, 2019 : PubMed

            

    Title: Expression, purification and crystallization of human prolylcarboxypeptidase.
    Abeywickrema PD, Patel SB, Byrne NJ, Diehl RE, Hall DL, Ford RE, Rickert KW, Reid JC, Shipman JM and Sharma S <5 more author(s)>
    Ref: Acta Crystallographica Sect F Struct Biol Cryst Commun, 66:702, 2010 : PubMed

            

    Title: Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase
    Soisson SM, Patel SB, Abeywickrema PD, Byrne NJ, Diehl RE, Hall DL, Ford RE, Reid JC, Rickert KW and Lumb KJ <2 more author(s)>
    Ref: BMC Struct Biol, 10:16, 2010 : PubMed

            

    Title: Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors
    Edmondson SD, Mastracchio A, Cox JM, Eiermann GJ, He H, Lyons KA, Patel RA, Patel SB, Petrov A and Weber AE <6 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 19:4097, 2009 : PubMed

            

    Title: Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
    Edmondson SD, Wei L, Xu J, Shang J, Xu S, Pang J, Chaudhary A, Dean DC, He H and Weber AE <8 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 18:2409, 2008 : PubMed

            

    Title: Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines
    Kim D, Kowalchick JE, Brockunier LL, Parmee ER, Eiermann GJ, Fisher MH, He H, Leiting B, Lyons K and Weber AE <11 more author(s)>
    Ref: Journal of Medicinal Chemistry, 51:589, 2008 : PubMed

            

    Title: 4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV
    Duffy JL, Kirk BA, Wang L, Eiermann GJ, He H, Leiting B, Lyons KA, Patel RA, Patel SB and Weber AE <4 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 17:2879, 2007 : PubMed

            

    Title: Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors
    Gao YD, Feng D, Sheridan RP, Scapin G, Patel SB, Wu JK, Zhang X, Sinha-Roy R, Thornberry NA and Biftu T <1 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 17:3877, 2007 : PubMed

            

    Title: 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV
    Kaelin DE, Smenton AL, Eiermann GJ, He H, Leiting B, Lyons KA, Patel RA, Patel SB, Petrov A and Duffy JL <4 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 17:5806, 2007 : PubMed

            

    Title: (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]tr iazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Edmondson SD, Mastracchio A, Mathvink RJ, He J, Harper B, Park YJ, Beconi M, Di Salvo J, Eiermann GJ and Weber AE <16 more author(s)>
    Ref: Journal of Medicinal Chemistry, 49:3614, 2006 : PubMed

            

    Title: Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors
    Xu J, Wei L, Mathvink RJ, Edmondson SD, Eiermann GJ, He H, Leone JF, Leiting B, Lyons KA and Weber AE <7 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 16:5373, 2006 : PubMed

            

    Title: (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, He H, Hickey GJ, Kowalchick JE, Leiting B and Weber AE <13 more author(s)>
    Ref: Journal of Medicinal Chemistry, 48:141, 2005 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer